Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2787 Target Snapshot

Metabotropic glutamate receptor 4 · SINGLE PROTEIN · Rattus norvegicus

365Compounds
120Assays
0Approved Drugs
462.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P31423. Use UniProt P31423 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P31423 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Metabotropic glutamate receptor 4 as ChEMBL target CHEMBL2787, mapped to UniProt P31423. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Metabotropic glutamate receptor 4
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL2787
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P31423
Metabotropic glutamate receptor 4
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Metabotropic glutamate receptor 4 is the right protein anchor across sources, using UniProt P31423 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelMetabotropic glutamate receptor 4
UniProt AccessionP31423
Component TypeProtein
Sequence Length912 aa

Metabotropic glutamate receptor 4

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Metabotropic glutamate receptor 4, mapped to UniProt P31423. Sequence length is 912 aa.

Mapped IDP31423
Review nameMetabotropic glutamate receptor 4
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

2
Phase III
2
Phase II
Assay Mix

Activity Type Distribution

IC5018.0
KI30.0
EC50414.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3357575 8.38 IC50 4.169 Preclinical
CHEMBL3357574 8.29 IC50 5.1 Preclinical
CHEMBL3609729 8.05 EC50 9.0 Preclinical
CHEMBL541754 8.0 IC50 9.9 Preclinical
CHEMBL3357576 7.93 IC50 11.75 Preclinical
CHEMBL562551 7.89 IC50 12.8 Preclinical
CHEMBL3114673 7.62 EC50 24.0 Preclinical
CHEMBL3357577 7.58 IC50 26.3 Preclinical
CHEMBL4067875 7.57 EC50 27.0 Preclinical
CHEMBL229697 7.52 EC50 30.0 Preclinical
Distribution

pChEMBL Value Distribution

42
5.0
40
5.5
54
6.0
52
6.5
29
7.0
14
7.5
7
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

120
Total Assays
122
Tested Compounds
2
Assay Types
Binding — 63 assays, 100 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 39 67 6.7
single protein format 21 26 6.2
assay format 3 7 5.5
Functional — 57 assays, 122 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 48 115 5.9
assay format 9 7 5.7

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine